Close

Innerpage

Press Releases

Sep 19, 2017

Meridian Contributes to Upcoming “LEADCON 2017” – Third Annual International Conference on the Prevention of Lead and Heavy Metal Toxicity in Hyderabad, India

read more
Sep 05, 2017

Meridian Launches TRU Block® ULTRA – A Powerful Immunoassay Interference Blocker

read more
Aug 09, 2017

Meridian Initiates Clinical Trials for New Neonatal Saliva CMV illumigene Test

read more
Aug 08, 2017

Meridian Bioscience Introduces the Expansion of Its ImmunoCard STAT!® Product Line

read more
Aug 08, 2017

Meridian Bioscience Elects John Rice to the Board of Directors

read more
Aug 02, 2017

Bioline Launches New JetSeq™ Clean Kit for Next-Generation Sequencing

read more
Jul 27, 2017

Meridian Bioscience Reports Third Fiscal Quarter 2017 Operating Results, Including Non-Cash Goodwill Impairment Charge,Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance Excluding the Effect of Goodwill Impairment Charge

read more
Jul 20, 2017

Meridian Announces Wholly Foreign Owned Enterprise (WFOE) Office in Beijing, China

read more
Jul 13, 2017

Meridian Bioscience Comments on Recent FDA Press Statement

read more
Jun 30, 2017

Meridian Bioscience Comments on Recent FDA Matters Related to Magellan Diagnostics

read more
Jun 28, 2017

Meridian Bioscience, Inc. Expects to Report Third Quarter Fiscal 2017 Operating Results on Thursday, July 27, 2017

read more
Jun 06, 2017

Meridian Bioscience Comments on Recent FDA Posting Related to Magellan Diagnostics

read more
May 17, 2017

Meridian Bioscience Comments on FDA Matter Involving its Subsidiary, Magellan Diagnostics

read more
May 10, 2017

Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire

read more
May 09, 2017

Magellan Diagnostics (Meridian Bioscience, Inc., NASDAQ: VIVO) Launches National Education Initiative on Risks of Lead Exposure for Pregnant Women

read more
May 04, 2017

Meridian Continues Its Fight Against Tropical Diseases by Introducing the Most Comprehensive Menu of Antigens and Antibodies for Diagnostic Applications

read more
Apr 27, 2017

Meridian Bioscience Reports Second Quarter 2017 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance

read more
Apr 26, 2017

Meridian Bioscience Inc. (Nasdaq: VIVO) to Ring The Nasdaq Stock Market Opening Bell

read more
Apr 24, 2017

New Testing Procedure Holds Promise As a Critical Tool in the Global Effort to Eliminate Malaria

read more
Apr 17, 2017

ECCMID Presentation to Demonstrate Revolutionary Breakthrough in Malaria Detection

read more